Paper35301281
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.
Risso V and 2 others. Cell Death Dis, 2022. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. Papers, record 35301281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35301281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Neoplasms | Major topic |
| Apoptosis | |
| Fas Ligand Protein | |
| Humans | |
| Inflammation | |
| fas Receptor |
Source PubMed
References430
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10485821 | Acute toxicity of an anti-Fas antibody in mice. | Toxicol Pathol | 1999 | https://conductscience.org/library/papers/10485821 | PubMed |
| 2 | 16619028 | Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. | EMBO J | 2006 | https://conductscience.org/library/papers/16619028 | PubMed |
| 3 | 30005714 | CART cells are prone to Fas- and DR5-mediated cell death. | J Immunother Cancer | 2018 | https://conductscience.org/library/papers/30005714 | PubMed |
| 4 | 11418480 | The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. | Blood | 2001 | https://conductscience.org/library/papers/11418480 | PubMed |
| 5 | 17290285 | ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. | Cell Death Differ | 2007 | https://conductscience.org/library/papers/17290285 | PubMed |
| 6 | 25723171 | Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. | Cell | 2015 | https://conductscience.org/library/papers/25723171 | PubMed |
| 7 | 7964507 | Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. | J Exp Med | 1994 | https://conductscience.org/library/papers/7964507 | PubMed |
| 8 | 22917034 | Cyclosporine A and bromocriptine attenuate cell death mediated by intracellular calcium mobilization. | BMB Rep | 2012 | https://conductscience.org/library/papers/22917034 | PubMed |
| 9 | 28424702 | Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance. | Front Immunol | 2017 | https://conductscience.org/library/papers/28424702 | PubMed |
| 10 | 25918278 | Toxicities of Immunotherapy for the Practitioner. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25918278 | PubMed |
| 11 | 34223817 | Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2. | Elife | 2021 | https://conductscience.org/library/papers/34223817 | PubMed |
| 12 | 12535213 | Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. | J Invest Dermatol | 2003 | https://conductscience.org/library/papers/12535213 | PubMed |
| 13 | 9643529 | Inhibition of systemic TNF-alpha cytotoxicity in cancer patients by D-peptidoglycan. | Med Oncol | 1998 | https://conductscience.org/library/papers/9643529 | PubMed |
| 14 | 15004554 | Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. | Nat Med | 2004 | https://conductscience.org/library/papers/15004554 | PubMed |
| 15 | 30692847 | Multiple Sclerosis: Diagnosis and Differential Diagnosis. | Noro Psikiyatr Ars | 2018 | https://conductscience.org/library/papers/30692847 | PubMed |
| 16 | 31564969 | Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31564969 | PubMed |
| 17 | 19596991 | Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. | J Immunol | 2009 | https://conductscience.org/library/papers/19596991 | PubMed |
| 18 | 9267021 | Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. | Cell | 1997 | https://conductscience.org/library/papers/9267021 | PubMed |
| 19 | 30413827 | Cytokines in clinical cancer immunotherapy. | Br J Cancer | 2019 | https://conductscience.org/library/papers/30413827 | PubMed |
| 20 | 9144461 | Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. | J Immunol | 1997 | https://conductscience.org/library/papers/9144461 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738255 | Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738255 | PubMed |
| 42450065 | Profiles of FGF2, HGF, Fas/CD95, CASP9, ALDH1A1, and GLUT1 in GEP-NETs: A Comparative Tumor-Margin Study Based on Protein Concentration. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450065 | PubMed |
| 42338608 | Rearming mesenchymal stem cells with engineering strategies to combat cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42338608 | PubMed |
| 42328431 | Role of WDR66 in Stemness, Therapy Resistance and Tumor microenvironment modulation in Head and Neck Cancer. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42328431 | PubMed |
| 42149394 | A Noncanonical Model of DED1 Interaction Betweenc-FLIPS and Procaspase-8. | Protein J | 2026 | https://conductscience.org/library/papers/42149394 | PubMed |
| 42038349 | Nobiletin in cancer therapy: Emerging insights into multi-target mechanisms, overcoming drug resistance and therapeutic translation (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42038349 | PubMed |
| 41972181 | The dual role of T cells in solid organ transplant rejection and immune tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/41972181 | PubMed |
| 41895266 | Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition. | Neuron | 2026 | https://conductscience.org/library/papers/41895266 | PubMed |
| 41870184 | The Trifecta of Polo-Like Kinases, Cancer, and the Immune System: Emerging Intersections and Therapeutic Insights. | Mol Cancer Res | 2026 | https://conductscience.org/library/papers/41870184 | PubMed |
| 41838231 | The Fas-FasL system: from apoptosis regulator to therapeutic target in autoimmunity, cancer, and transplantation. | Immunol Res | 2026 | https://conductscience.org/library/papers/41838231 | PubMed |
| 41733612 | Exploring apoptotic pathways: implications for cancer, inflammation, and neurodegeneration. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41733612 | PubMed |
| 41634378 | CMTM6 suppresses cell-surface expression of death receptor FAS in mice but not in humans. | EMBO Rep | 2026 | https://conductscience.org/library/papers/41634378 | PubMed |
| 41473700 | Dual role of IFNγ in reprogramming the undifferentiated pleomorphic sarcoma cell line JBT19 towards cytotoxic chemotherapy and antitumor immunity. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41473700 | PubMed |
| 41304752 | Camptothecin in Cancer Therapy: Current Challenges and Emerging Strategies with Nanoemulsions. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304752 | PubMed |
| 41294018 | Genetic Crosstalk Between Type 1 Diabetes and Sjögren's Syndrome: A Systematic Exploration of Risk Genes and Common Pathways. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41294018 | PubMed |
| 40872940 | Multisystem Endothelial Inflammation: A Key Driver of Adverse Events Following mRNA-Containing COVID-19 Vaccines. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872940 | PubMed |
| 40735287 | Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration. | Brain Behav Immun Health | 2025 | https://conductscience.org/library/papers/40735287 | PubMed |
| 40330016 | FAS mediates apoptosis, inflammation, and treatment of pathogen infection. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40330016 | PubMed |
| 39924583 | The complexities of cell death mechanisms: a new perspective in systemic sclerosis therapy. | Apoptosis | 2025 | https://conductscience.org/library/papers/39924583 | PubMed |
| 39866364 | Systemic Lupus Erythematous: Gene Polymorphisms, Epigenetics, Environmental, Hormonal and Nutritional Factors in the Consideration of Personalized Therapy. | Arch Intern Med Res | 2024 | https://conductscience.org/library/papers/39866364 | PubMed |
Genes97
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35301281
GET https://conductscience.org/api/papers/v1/35301281/references?page=2